[HTML][HTML] Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
The Lancet, 2021•thelancet.com
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals - The
Lancet Skip to Main Content Advertisement The Lancet Journal Submit Article Log in Register
Log in Submit Article Log in Subscribe Skip menu This journal Read Online first Current issue
All issues Special issues Series Commissions About About the journal Alerts Request
institutional access External Link Multimedia Podcasts External Link Journals Journals The
Lancet The Lancet Child & Adolescent Health The Lancet Diabetes & Endocrinology The Lancet …
Lancet Skip to Main Content Advertisement The Lancet Journal Submit Article Log in Register
Log in Submit Article Log in Subscribe Skip menu This journal Read Online first Current issue
All issues Special issues Series Commissions About About the journal Alerts Request
institutional access External Link Multimedia Podcasts External Link Journals Journals The
Lancet The Lancet Child & Adolescent Health The Lancet Diabetes & Endocrinology The Lancet …
Most vaccine platforms use a two-dose prime-boost approach to generate an immune response against the virus S1 spike protein, the titres of which correlate with functional virus neutralisation and increase with boosting.
thelancet.com